These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37204706)

  • 21. Laboratory testing of anticoagulants: the present and the future.
    Favaloro EJ; Lippi G; Koutts J
    Pathology; 2011 Dec; 43(7):682-92. PubMed ID: 22081129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory assessment of novel oral anticoagulants: method suitability and variability between coagulation laboratories.
    Helin TA; Pakkanen A; Lassila R; Joutsi-Korhonen L
    Clin Chem; 2013 May; 59(5):807-14. PubMed ID: 23378569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comprehensive model for the humoral coagulation network in humans.
    Wajima T; Isbister GK; Duffull SB
    Clin Pharmacol Ther; 2009 Sep; 86(3):290-8. PubMed ID: 19516255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanomechanical clinical coagulation diagnostics and monitoring of therapies.
    Padovani F; Duffy J; Hegner M
    Nanoscale; 2017 Nov; 9(45):17939-17947. PubMed ID: 29125171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prothrombin time and thromboplastin time. On-site measurement of the prothrombin time and activated partial thromboplastin time of surgical patients with laser photometry].
    Tschaikowsky K; Balint R; Pscheidl E; Bremer F
    Anaesthesist; 1998 Apr; 47(4):295-302. PubMed ID: 9615846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of coagulation parameters in plasma samples at room temperature after one freeze/thaw cycle.
    Gaudard M; Boissier E; Talon L; Douxfils J; Sapin AF; Sinegre T; Lebreton A
    Int J Lab Hematol; 2022 Jun; 44(3):610-618. PubMed ID: 35029031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults.
    Kamal AH; Tefferi A; Pruthi RK
    Mayo Clin Proc; 2007 Jul; 82(7):864-73. PubMed ID: 17605969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Policies and practices in haemostasis testing among laboratories in Croatia: a survey on behalf of a Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine.
    Bronić A; Herak DC; Margetić S; Milić M
    Biochem Med (Zagreb); 2017 Feb; 27(1):199-216. PubMed ID: 28392741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variability of prothrombin time and activated partial thromboplastin time in the diagnosis of increased surgical bleeding.
    Murray D; Pennell B; Olson J
    Transfusion; 1999 Jan; 39(1):56-62. PubMed ID: 9920167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Q analyzer, a new cap-piercing fully automated coagulometer with clotting, chromogenic, and immunoturbidometric capability.
    Kitchen S; Woolley A
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):28-34. PubMed ID: 23249565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Monitoring of coagulation status in the physician's laboratory].
    Marbet GA
    Ther Umsch; 1995 May; 52(5):343-9. PubMed ID: 7770821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Considerations in the laboratory assessment of haemostasis.
    McCraw A; Hillarp A; Echenagucia M
    Haemophilia; 2010 Jul; 16 Suppl 5():74-8. PubMed ID: 20590860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single-institution retrospective study of causes of prolonged prothrombin time and activated partial thromboplastin time in the outpatient setting.
    Hazim AZ; Ruan GJ; Khodadadi RB; Slusser JP; Marshall AL; Pruthi RK
    Int J Lab Hematol; 2022 Feb; 44(1):209-215. PubMed ID: 34612006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants.
    Ebner M; Birschmann I; Peter A; Spencer C; Härtig F; Kuhn J; Blumenstock G; Zuern CS; Ziemann U; Poli S
    Crit Care; 2017 Feb; 21(1):32. PubMed ID: 28196509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergency medicine misconceptions: Utility of routine coagulation panels in the emergency department setting.
    Long B; Long DA; Koyfman A
    Am J Emerg Med; 2020 Jun; 38(6):1226-1232. PubMed ID: 32029342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The PiCT
    Brisset AC; Ferrández A; Krause M; Rathbun S; Marlar R; Korte W
    J Thromb Haemost; 2016 Nov; 14(11):2187-2193. PubMed ID: 27582411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors.
    Favaloro EJ; Kershaw G; Mohammed S; Lippi G
    Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing.
    Adcock DM; Kressin DC; Marlar RA
    Am J Clin Pathol; 1997 Jan; 107(1):105-10. PubMed ID: 8980376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving the inter-laboratory harmonization of the international normalized ratio (INR): utilizing the concept of transference to estimate and/or validate international sensitivity index (ISI) and mean normal prothrombin time (MNPT) values and/or to eliminate measurement bias.
    Favaloro EJ; McVicker W; Zhang Y; Hamdam S; Huynh M; Peris P; O'Neal M; Hocker N
    Clin Lab Sci; 2012; 25(1):13-25. PubMed ID: 22458045
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.